Inotiv, Inc. (NOTVQ)
OTCMKTS · Delayed Price · Currency is USD
0.0120
+0.0039 (48.15%)
At close: Jun 26, 2026
Inotiv Revenue
Inotiv had revenue of $117.65M in the quarter ending March 31, 2026, a decrease of -5.37%. This brings the company's revenue in the last twelve months to $507.36M, up 5.61% year-over-year. In the fiscal year ending September 30, 2025, Inotiv had annual revenue of $513.02M with 4.54% growth.
Revenue (ttm)
507.36M
Revenue Growth
+5.61%
P/S Ratio
0.00
Revenue / Employee
254.19K
Employees
2,046
Market Cap
418.66K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 513.02M | 22.29M | 4.54% |
| Sep 30, 2024 | 490.74M | -81.69M | -14.27% |
| Sep 30, 2023 | 572.43M | 24.77M | 4.52% |
| Sep 30, 2022 | 547.66M | 458.05M | 511.19% |
| Sep 30, 2021 | 89.61M | 29.14M | 48.18% |
| Sep 30, 2020 | 60.47M | 16.85M | 38.64% |
| Sep 30, 2019 | 43.62M | 17.27M | 65.55% |
| Sep 30, 2018 | 26.35M | 2.10M | 8.68% |
| Sep 30, 2017 | 24.24M | 3.80M | 18.59% |
| Sep 30, 2016 | 20.44M | -2.26M | -9.94% |
| Sep 30, 2015 | 22.70M | -1.89M | -7.67% |
| Sep 30, 2014 | 24.58M | 2.52M | 11.40% |
| Sep 30, 2013 | 22.07M | -6.14M | -21.77% |
| Sep 30, 2012 | 28.21M | -4.94M | -14.89% |
| Sep 30, 2011 | 33.14M | 4.36M | 15.16% |
| Sep 30, 2010 | 28.78M | -3.00M | -9.45% |
| Sep 30, 2009 | 31.78M | -9.91M | -23.77% |
| Sep 30, 2008 | 41.70M | 1.94M | 4.89% |
| Sep 30, 2007 | 39.75M | -3.30M | -7.65% |
| Sep 30, 2006 | 43.05M | 653.00K | 1.54% |
| Sep 30, 2005 | 42.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Psychemedics | 19.69M |
| T2 Biosystems | 7.68M |
| Medical Imaging | 7.52M |
| ProPhase Labs | 4.35M |
| Longduoduo Company | 2.13M |
| IDenta | 1.69M |
| InVitro International | 811.29K |
| NovelStem International | 3.00K |
Inotiv News
- 24 days ago - Inotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future Growth - Business Wire
- 4 months ago - Inotiv Provides Notice Regarding Cybersecurity Incident - GlobeNewsWire
- 4 months ago - Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update - GlobeNewsWire
- 5 months ago - Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026 - GlobeNewsWire
- 5 months ago - Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery - GlobeNewsWire
- 7 months ago - Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - GlobeNewsWire
- 7 months ago - Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update - GlobeNewsWire
- 7 months ago - Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™ - GlobeNewsWire